The costs of adverse drug events in hospitalized patients

Journal of the American Medical Association

Volumn 277, Issue 4, 1997, Pages 307-311

  Bates, David W ^a   Spell, Nathan ^a   Cullen, David J ^b   Burdick, Elisabeth ^c   Laird, Nan ^c   Petersen, Laura A ^d   Small, Stephen D ^b   Sweitzer, Bobbie J ^b   Leape, Lucian L ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Management Decision and Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; NEUROLEPTIC AGENT; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; DRUG INDUCED DISEASE; FEMALE; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031012726     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.4.307     Document Type: Article

References (23)

1. Brennan TA, Leape LL, Laird N, et al. Incidence of adverse events and negligence in hospitalized patients: results from the Harvard Medical Practice Study I. N Engl J Med. 1991;324:370-376.
2. Leape LL, Brennan TA, Laird NM, et al. The nature of adverse events in hospitalized patients: results from the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377-384.
3. Bates DW, Cullen D, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995; 274:29-34.
4. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA. 1995;274: 35-43.
5. Koska MT. Drug errors: dangerous, costly, and avoidable. Hospitals. June 5, 1989;63:24.
6. Korin J. Cost implications of malpractice and adverse events. Hosp Formulary. January 1993; 28(suppl 1):59-61.
7. Evans RS, Classen DC, Stevens LE, et al. Using a hospital information system to assess the effects of adverse drug events. Proc Annu Symp Comput Appl Med Care. 1993;17:161-165.
8. National Association of Insurance Commissioners. Medical Malpractice Closed Claims, 1975-1978. Brookfield, Wis: National Association of Insurance Commissioners; 1980.
9. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995;155:1949-1956.
10. Sandrick K. Cut to the quick: hospitals face bleak choices as Congress debates Medicare's future. Hosp Health Networks. July 20, 1995;69:36, 38, 40.
11. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993;8:289-294.
12. Cullen DJ, Nemeskal AR. Therapeutic Intervention Scoring System (TISS). Prob Crit Care. 1989;3:545-562.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal populations: development and validation. J Chronic Dis. 1987;40:373-383.
14. Welch HG, Larson EB. Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med. 1989;321:807-812.
15. Rogowski JR, Byrne DJ. Comparison of alternative weight recalibration methods for diagnosis-related groups. Health Care Financ Rev. 1990;12: 87-101.
16. SAS Procedures Guide, Release 6.03 Edition. Cary, NC: SAS Institute Inc; 1988.
17. Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariable Methods. Boston, Mass: PWS-Kent; 1988.
18. American Hospital Association. Hospital Statistics. Chicago, Ill: American Hospital Association; 1993.
19. America's best hospitals. US News & World Report. August 12, 1996:67-87.
20. McKenney JM, Harrison WL. Drug-related hospital admissions. Am J Hosp Pharm. 1976;33:792-795.
21. Einarson TR. Drug-related hospital admissions. Ann Pharmacother: 1993;27:832-840.
22. Finkler SA. The distinction between costs and charges. Ann Intern Med. 1982;96:102-109.
23. Thorpe KE. Inside the black box of administrative costs. Health Aff (Millwood). Summer 1992; 11:41-55.